Ceporex 180 mg/ml Suspension for Injection for Cattle, Cats and Dogs

País: Reino Unido

Idioma: inglés

Fuente: VMD (Veterinary Medicines Directorate)

Ingredientes activos:

Cefalexin

Disponible desde:

MSD Animal Health UK Limited

Código ATC:

QJ01DB01

Designación común internacional (DCI):

Cefalexin

formulario farmacéutico:

Suspension for injection

tipo de receta:

POM-V - Prescription Only Medicine – Veterinarian

Grupo terapéutico:

Cats, Cattle, Dogs

Área terapéutica:

Antimicrobial

Estado de Autorización:

Authorized

Fecha de autorización:

1992-12-23

Ficha técnica

Revised: March 2022
AN: 02403/2021
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF VETERINARY MEDICINAL PRODUCT
Ceporex 180 mg/ml Suspension for Injection for Cattle, Cats and Dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active constituents:
mg/ml
Cefalexin sodium
equivalent to Cefalexin
180
For a full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Suspension for injection
A white to cream coloured mobile suspension
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle, cats and dogs.
4.2
INDICATIONS FOR USE
The product is indicated for antibiotic therapy in cattle, cats and
dogs. Cefalexin is a
broad spectrum cefalosporin antibiotic with bactericidal activity
against a wide
range of Gram-positive and Gram-negative bacteria.
The following micro-organisms have been shown to be sensitive to
cefalexin _ in _
_vitro:_
_Staphylococcus_ spp. (including penicillin-resistant strains)
_Streptococcus_ spp.
_Actinomyces bovis_
_Corynebacterium_ spp.
_Haemophilus_ spp.
_Pasteurella_ spp.
_Erysipelothrix rhusiopathiae_
_Escherichia_ _coli_
_Clostridium_ spp.
_Proteus_ spp.
_Salmonella_ spp.
_Micrococcus_ spp.
_Fusobacterium_ spp.
_Moraxella_ spp.
_Peptostreptococcus_ spp.
_Actinobacillus_ _lignieresi_
_Peptococcus_ spp.
When susceptible organisms are present, the product is indicated in
the treatment
of
infections
of
the
respiratory
tract,
urogenital
tract,
the
skin
and
localised
infections in soft tissues in dogs and cats. In dogs it may also be
effective in the
treatment of infections of the gastrointestinal tract.
Revised: March 2022
AN: 02403/2021
Page 2 of 5
Trials have shown the product to be of particular value in treating
metritis, foot
infections, wounds and abscesses and in the treatment of septicaemic
mastitis to
supplement intramammary therapy in cattle.
4.3
CONTRA-INDICATIONS
Hypersensitivity to cefalexin is very rare, however, it should not be
administered to
animals which are known to be hypersensitive.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
As with other antibiotics which are excret